Hepatitis C

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hepatitis C virus (HCV) is the prototype human pathogen having been discovered purely by molecular biology rather than by traditional virology tools. Since the early 1970s, the existence of a virus responsible for the majority of parenterally transmitted non-A, non-B hepatitis had been suspected, but it was not until 1989 that Michael Houghton and coworkers, at Chiron Corporation, identified and cloned HCV. It took another 10 years to develop an efficient system to study HCV replication in vitro, thus paving the way to large-scale screening of small molecules with direct antiviral activity. Meanwhile, the details of the HCV transmission, pathogenesis and natural history were unravelled, leading to a full appreciation of the global health burden associated with this infection. HCV affects about 2.4 % of the world population, and molecular biology advances may again contribute substantially—through the development of safe and efficacious drugs—to its eradication in the near future. The main focus of this chapter is to provide an overview of the innate and adaptive immune responses against HCV. In addition, we will describe the latest developments in the treatment of acute and chronic hepatitis C.

Original languageEnglish
Title of host publicationLiver Immunology: Principles and Practice
PublisherSpringer International Publishing
Pages207-230
Number of pages24
ISBN (Print)9783319020969, 9783319020952
DOIs
Publication statusPublished - Jan 1 2014

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mondelli, M. U., Varchetta, S., & Negro, F. (2014). Hepatitis C. In Liver Immunology: Principles and Practice (pp. 207-230). Springer International Publishing. https://doi.org/10.1007/978-3-319-02096-9_15